MUNDIPHARMA has awarded $60,000 to Dr Kate Mahon, a medical oncologist at Chris O'Brien Lifehouse, to support her research into prostate cancer.
It's the fifth annual Clinical Research Fellowship to be awarded in partnership with the Australian and NZ Urogenital and Prostate Cancer Trials Group (ANZUP).
The Fellowship was previously awarded by Tolmar Australia, which Mundipharma acquired in Feb.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jul 18
